References
- Food and Drug Administration Safety and Innovation Act (FDASIA). Public Law 112–144, 126 Stat. 993. Available at: http://www.govtrack.us/congress/bills/112/s3187/text [Accessed 15 November 2012].
- Burda AM, Sigg T, Haque D, Bardsley CH. Inadequate pyridoxine stock and its effect on patient outcome. Am J Ther 2007; 14: 262–264.
- Dart RC, Borron SW, Caravati EM, Cobaugh DJ, Curry SC, Falk JL, et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med 2009; 54: 386–394.e1.
- Dart RC, Stark Y, Fulton B, Koziol-McLain J, Lowenstein SR. Insufficient stocking of poisoning antidotes in hospital pharmacies. JAMA 1996; 276:1508–1510.
- Morrow LE, Wear RE, Schuller D, Malesker M. Acute isoniazid toxicity and the need for adequate pyridoxine supplies. Pharmacotherapy 2006; 26:1529–1532.
- Teresi WM, King WD. Survey of the stocking of poison antidotes in Alabama hospitals. South Med J 1999; 92:1151–1156.
- Woolf AD, Chrisanthus K. On-site availability of selected antidotes: results of a survey of Massachusetts hospitals. Am J Emerg Med 1997; 15:62–66.
- McFee RB, Caraccio TR, Gamble VN. Understocking antidotes for common toxicologic emergencies: a neglected public health problem. Johns Hopkins Adv Stud Med 2005; 5:262–263.
- American Society of Health-System Pharmacists. Drug Shortages: Current Drugs. 2012. Available at: http://www.ashp.org/menu/DrugShortages/CurrentShortages.aspx [Accessed 15 November 2012].
- Azoulay S. Antivenin (Micrurus fulvius) (Equine Origin). North American Coral Snake Antivenin. Further Extension of Expiration Dating To October 31, 2012. LOT No. 4030026. [Dear Health Care Provider Letter]. New York, NY: Pfizer Inc.; 2011.
- U.S. Department of Homeland Security. Target Capabilities List. A companion to the National Preparedness Guidelines. 2007. Available at: http://www.fema.gov/pdf/government/training/tcl.pdf [Accessed 15 November 2012].
- Greenberg MI, Jurgens SM, Gracely EJ. Emergency department preparedness for the evaluation and treatment of victims of biological or chemical terrorist attack. J Emerg Med 2002; 22:273–278.
- Keim ME, Pesik N, Twum-Danso NA. Lack of hospital preparedness for chemical terrorism in a major US city: 1996-2000. Prehosp Disaster Med 2003; 18:193–199.
- Code of Federal Regulations. Title 21 (Food and Drugs). Chapter 1 (Food and Drug Administration Department of Health and Human Services). Subchapter C (Drugs: General). Part 211 (Current Good Manufacturing Practices for Finished Pharmaceuticals). Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart = 211&showFR = 1 [Accessed 15 November 2012].
- Lyon RC, Taylor JS, Porter DA, Prasanna HR, Hussain AS. Stability profiles of drug products extended beyond labeled expiration dates. J Pharm Sci 2006; 95:1549–1560.
- [No author listed]. Drugs Past their expiration date. Med Lett Drugs Ther 2009; 51:100–101.
- Hoffman RS, Mercurio-Zappala M, Bouchard N, Ravikumar P, Goldfrank L. Preparing for chemical terrorism: a study of the stability of expired pralidoxime (2-PAM). Disaster Med Public Health Prep 2012; 6:20–25.
- The 2012 Florida Statutes. Florida Drug and Cosmetic Act; 499.006(9), 499.005(1), and 499.005(3). Available at: http://www.leg.state.fl.us/statutes/index.cfm?App_mode = Display_Statute&URL = 0400–0499/0499/0499.html [Accessed 15 November 2012].
- American College of Medical Toxicology. ACMT Position Statement: Institutions housing venomous animals. 2012. Available at: http://www.acmt.net/cgi/page.cgi?aid = 4005&_id = 462&zine = show [Accessed 15 November 2012].
- Food and Drug Administration CfDEaR. Guidance for federal agencies and state and local govenments. Potassium iodide tablets shelf life extension. Rockville, MD: U.S. Department of Health and Human Service; 2004.
- Department of Defense. Shelf Life Management Manual. DOD 4140.27-M/DLA J-373. 2003. Available at: http://www.shelflife.hq.dla.mil/policy_DoD4140_27.aspx [Accessed 15 November 2012].
- Marraffa JM, Cohen V, Howland MA. Antidotes for toxicological emergencies: a practical review. Am J Health Syst Pharm 2012; 69:199–212.